Philips broadens Inturis for Cardiology
Philips broadens Inturis for CardiologyEyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated
Philips broadens Inturis for Cardiology
Eyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated image and information system product line. Inturis NT is an entry-level solution for small to medium facilities with a single cath lab system that are seeking a cost-effective way to replace film with digital imaging and storage, according to the Shelton, CT-based firm. Inturis Lite is designed for departments with two to three labs and moderate imaging volume that want networking capabilities.
Philips has also released an advanced version of its original Inturis On-line system, Inturis On-line 2.2, for larger, high-volume departments with multiple labs from various manufacturers. All three products debuted at the TransCatheter Cardiovascular Therapeutics meeting in Washington, DC, last month.
- Search again
- Homepage
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
